MACUCLEAR
MacuCLEAR Inc.â„¢ is a specialty clinical-stage pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye. MacuCLEAR has an active IND for MC-1101 and has completed a novel and successful Phase Ib/POC human clinical trial.
MACUCLEAR
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Plano, Texas, United States
Country:
United States
Website Url:
http://www.macuclear.com
Total Employee:
11+
Status:
Active
Contact:
214-577-5999
Total Funding:
1000 K USD
Technology used in webpage:
SPF Amazon Facebook Sharer Amazon Ohio Region Reddit NameBright
Similar Organizations
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Current Advisors List
Board_member
Current Employees Featured
George Chiou Co-Founder @ MacuCLEAR
Co-Founder
Founder
Official Site Inspections
http://www.macuclear.com
- Host name: ec2-3-18-7-81.us-east-2.compute.amazonaws.com
- IP address: 3.18.7.81
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "MacuCLEAR"
MacuClear 2025 Company Profile: Valuation, Investors ... - PitchBook
MacuClear General Information Description. Developer of small molecule products for ophthalmic treatments for age-related diseases of the eye. The company offers MC-1101 eye drops for …See details»
MacuCLEAR, Inc. Company Profile | Plano, TX - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MacuCLEAR, Inc. of Plano, TX. Get the latest business insights from Dun & Bradstreet.See details»
MacuCLEAR - VentureRadar
"MacuCLEAR is focused on the design and development of small molecule products for ophthalmic treatments for agerelated diseases of the eye. MacuCLEAR is developing …See details»
MacuCLEAR Inc - Company Profile and News - Bloomberg Markets
Company profile page for MacuCLEAR Inc including stock price, company news, executives, board members, and contact informationSee details»
MacuCLEAR - Ownership and Business Overview - Mergr
May 4, 2010 MacuCLEAR was founded in 2006. Life Science M&A Summary in 2010. Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2010. The largest …See details»
MacuCLEAR, Inc. - Company Profile & Staff Directory - ContactOut
MacuCLEAR, Inc. is a clinical-stage specialty pharmaceutical company focused on developing innovative treatments for vascular and retinal diseases of the eye. Its lead compound MC …See details»
MacuCLEAR - 2025 Company Profile, Funding & Competitors
Mar 28, 2025 MacuCLEAR is an acqui-hired company based in Richardson (United States), founded in 2006. It operates as a Small molecule therapeutics for ophthalmology delivered via …See details»
MacuCLEAR - Funding, Financials, Valuation & Investors
MacuCLEAR focuses on discovering and developing novel solutions for vascular disorders of the eye. New. Resources. ... Experience the new Crunchbase, powered by AI . Experience the …See details»
MacuCLEAR, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore MacuCLEAR, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, Drug:Hydralazine Hydrochloride, MC-1101, MC-4001. ... The statistics for drugs in the …See details»
MacuClear - Products, Competitors, Financials, Employees, …
MacuCLEAR Inc Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, …See details»
MacuCLEAR, Inc.:Company Profile & Technical …
MacuCLEAR is headquartered in United States Texas. MacuCLEAR was founded in 2006. and was founded by George Chiou. MacuCLEAR has a total of 13 patents . Related Topics. …See details»
Healthcare of Today Acquires Pharmaceutical Company Treating …
May 5, 2010 MacuCLEAR intends to begin a Phase II clinical trial this summer. MacuCLEAR's accomplished management team also includes CSO and Co-Founder, George C. Y. Chiou, …See details»
Healthcare of Today acquires Macuclear/dry AMD technology
May 4, 2010 Macuclear has an active IND for MC-1101 and has completed a successful Phase Ib/Proof of Concept human clinical trial. The company intends to begin a Phase II clinical trial …See details»
MacuCLEAR - Contacts, Employees, Board Members, Advisors
MacuCLEAR focuses on discovering and developing novel solutions for vascular disorders of the eye. New. Resources. Advanced Search ... Experience the new Crunchbase, powered by AI . …See details»
MacuCLEAR Inc. - insights.citeline.com
Jul 1, 2009 MacuCLEAR's lead molecule for AMD, based on a marketed anti-hypertensive, stimulates choroidal blood flow so that cellular wastes in the eye can be cleared and never …See details»
MacuCLEAR - Texas A&M Innovation
MacuCLEAR, Inc. is focused on the design and development of small molecule products for ophthalmic treatments for age related diseases of the eye. MacuCLEAR is developing …See details»
MacuCLEAR, Inc. To Begin Phase III Study of its Lead Compound …
Apr 11, 2012 MacuCLEAR, Inc. is a clinical-stage specialty pharmaceutical company focused on developing innovative treatments for vascular and retinal diseases of the eye. Its lead …See details»
MacuCLEAR - Tech Stack, Apps, Patents & Trademarks - Crunchbase
MacuCLEAR uses 11 technology products and services including HTML5, Google Drive, and Vimeo, according to G2 Stack. MacuCLEAR is actively using 6 technologies for its website, …See details»
MC 1101 - AdisInsight - Springer
Feb 23, 2021 MacuCLEAR, a joint venture between UT Austin and Texas A&M University, is developing MC 1101, a patented, small molecule topical eye drop, for the treatment ... If your …See details»
Continuous Ranibizumab via Port Delivery System vs Monthly …
World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. World Health Organization; 2006. 30. Khanani AM, Graff JM, Marcus …See details»